Exeter V40短翻修型(44/00/125)股骨柄用于初次全髋关节置换术的生存率
基于英国国家关节登记处(NJR)截至2018年12月的328,737例使用Exeter V40股骨柄的初次全髋关节置换术(THA),44/00/125股骨柄植入2,158例,十年翻修估计值为4.9%(95%CI 3.6至6.8),校正后翻修风险比(HR)为1.8(95%CI 1.4至2.3),高于其他Exeter V40股骨柄,但仍在NICE十年基准内。
要点
- 44/00/125股骨柄用于初次THA的十年翻修估计值为4.9%(95%CI 3.6至6.8)。
- 校正年龄、性别、手术年份、适应证和ASA分级后,44/00/125股骨柄的翻修风险比为1.8(95%CI 1.4至2.3)。
- 作者认为翻修估计值在NICE十年基准内,但生存率似乎低于其他型号,仅在其他植入物不适用时使用。
核心结论
- 使用44/00/125股骨柄的构建体十年翻修估计值为4.9%(95%CI 3.6至6.8),校正后翻修风险比(HR)为1.8(95%CI 1.4至2.3),高于其他Exeter V40股骨柄;作者认为翻修估计值在NICE十年基准内,但生存率似乎低于其他型号,仅在其他植入物不适用时使用。
研究设计与样本
- 分析NJR中自登记开始至2018年12月的328,737例使用Exeter V40股骨柄的初次THA,占同期958,869例初次THA的34.3%,暴露为股骨柄,结局为全因构建体翻修,分为44/00/125、44/0/150、35.5/125和其他Exeter V40股骨柄四组。
主要发现
- 全部328,737例使用Exeter V40股骨柄的THA翻修估计值为2.8%(95%CI 2.7至2.8)。
- 44/00/125股骨柄植入2,158例初次THA,十年翻修估计值为4.9%(95%CI 3.6至6.8)。
- 校正年龄、性别、手术年份、适应证和ASA分级后,使用44/00/125股骨柄的构建体相比使用其他Exeter V40股骨柄的构建体,总体翻修风险比为1.8(95%CI 1.4至2.3)。
临床怎么用
- 作者认为外科医生和患者应感到放心,但需注意观察到的翻修估计值升高,仅在其他植入物不适用时使用该股骨柄。
局限性
- 校正分析不会考虑「适应证混杂」,例如解剖复杂的患者可能翻修风险更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Exeter V40 femoral stem is the most implanted stem in the National Joint Registry (NJR) for primary total hip arthroplasty (THA). In 2004, the 44/00/125 stem was released for use in 'cement-in-cement' revision cases. It has, however, been used 'off-label' as a primary stem when patient anatomy requires a smaller stem with a 44 mm offset. We aimed to investigate survival of this implant in comparison to others in the range when used in primary THAs recorded in the NJR. We analyzed 328,737 primary THAs using the Exeter V40 stem, comprising 34.3% of the 958,869 from the start of the NJR to December 2018. Our exposure was the stem, and the outcome was all-cause construct revision. We stratified analyses into four groups: constructs using the 44/00/125 stem, those using the 44/0/150 stem, those including a 35.5/125 stem, and constructs using any other Exeter V40 stem. In all 328,737 THAs using an Exeter V40 stem, the revision estimate was 2.8% (95% confidence interval (CI) 2.7 to 2.8). The 44/00/125 stem was implanted in 2,158 primary THAs, and the ten-year revision estimate was 4.9% (95% CI 3.6 to 6.8). Controlling for age, sex, year of operation, indication, and American Society of Anesthesiologists grade demonstrated an increased overall hazard of revision for constructs using the 44/00/125 stem compared to constructs using other Exeter V40 femoral stems (hazard ratio 1.8 (95% CI 1.4 to 2.3)). Although the revision estimate is within the National Institute for Health and Care Excellence ten-year benchmark, survivorship of constructs using the 44/00/125 stem appears to be lower than the rest of the range. Adjusted analyses will not take into account 'confounding by indication', e.g. patients with complex anatomy who may have a higher risk of revision. Surgeons and patients should be reassured but be aware of the observed increased revision estimate, and only use this stem when other implants are not suitable.
引用
- Evans JT, Salar O, Whitehouse SL, et al. Survival of the Exeter V40 short revision (44/00/125) stem when used in primary total hip arthroplasty. Bone Joint J. 2023. PMID: 37121595. doi:10.1302/0301-620X.105B5.BJJ-2022-1124.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。